bezafibrate has been researched along with Alcohol Drinking in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blednov, YA; Ferguson, LB; Harris, RA; Most, D | 1 |
| Benavidez, JM; Black, M; Blednov, YA; Edenberg, HJ; Ferguson, LB; Foroud, T; Goate, AM; Harris, RA; Hesselbrock, V; Schoenhard, GL; Wetherill, L | 1 |
| Fujioka, S; Nagoya, T; Oshida, S; Shimamura, M; Tsukamoto, S | 1 |
| Hamada, N; Inomata, T; Kariya, S; Murata, Y; Nishioka, A; Ogawa, Y; Saibara, T; Terashima, M; Yoshida, S | 1 |
4 other study(ies) available for bezafibrate and Alcohol Drinking
| Article | Year |
|---|---|
PPAR agonists regulate brain gene expression: relationship to their effects on ethanol consumption.
Topics: Alcohol Drinking; Alkanesulfonates; Amygdala; Animals; Bezafibrate; Central Nervous System Agents; Central Nervous System Depressants; Drinking; Drinking Water; Ethanol; Fenofibrate; Gene Expression; Liver; Male; Mice, Inbred C57BL; Peroxisome Proliferator-Activated Receptors; Phenylpropionates; Prefrontal Cortex; Taste Perception | 2014 |
Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.
Topics: Adult; Alcohol Drinking; Alcoholism; Alkanesulfonates; Animals; Bezafibrate; Brain; Female; Fenofibrate; Genome-Wide Association Study; Humans; Liver; Male; Mice; Phenylpropionates; Pioglitazone; Polymorphism, Single Nucleotide; PPAR alpha; PPAR gamma; Thiazoles; Thiazolidinediones | 2015 |
Effects of bezafibrate on erythrocyte membrane phospholipids in alcohol-treated rats.
Topics: Alcohol Drinking; Animals; Arachidonic Acid; Bezafibrate; Biomarkers; Erythrocyte Membrane; Fatty Acids; Hypolipidemic Agents; Male; Membrane Fluidity; Membrane Lipids; Phospholipids; Rats; Rats, Wistar | 1996 |
Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.
Topics: Alanine Transaminase; Alcohol Drinking; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Bezafibrate; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Cholesterol; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogen Receptor Modulators; Fatty Liver; Female; Fluorouracil; Humans; Mastectomy, Segmental; Middle Aged; Radiotherapy, Adjuvant; Tamoxifen; Tomography, X-Ray Computed; Toremifene | 2000 |